Folks with asthma might better control their symptoms by precisely timing when they use their inhaler, a new study says.

Sanofi (NASDAQ:SNY) announced Tuesday that its TIDE-Asthma Phase 2 study for its T-cell-depleting monoclonal antibody ...

You're also at a higher risk if you have a family history of anaphylaxis or have asthma. Anaphylaxis and its symptoms usually happen in stages. But it can worsen fast. Your symptoms are likely ...

The Asthma and Allergy Foundation of America has ... The report ranks the top 100 U.S. cities based on pollen levels, over-the-counter allergy medication use and access to allergists.

Among the children studied, 12.3 percent had asthma at the time of their 4- to 6-year checkup and 15.8 percent had wheezing.

Studies have shown that breathing air with high levels of fine particulate matter, nitrogen dioxide and other environmental pollutants can increase children's risk of developing asthma.

Climate change is causing a notable increase in pediatric asthma cases due to rising air pollution, temperatures, and allergens. Immediate action is r ...

Children exposed to higher levels of ambient ozone in their first 2 years of life are more likely to develop asthma by age 6 years, a new study finds.

A new study reveals that slight increases in ozone pollution during a child’s first two years can raise asthma and wheezing ...

Analysts at Leerink agreed with Sanofi that, despite falling short of statistical significance in the Phase II TIDE-Asthma trial, amlitelimab warrants further development in this indication.